AstraZeneca PLC
OTC:AZNCF

Watchlist Manager
AstraZeneca PLC Logo
AstraZeneca PLC
OTC:AZNCF
Watchlist
Price: 188.5 USD -1.19% Market Closed
Market Cap: 292.2B USD

Relative Value

The Relative Value of one AZNCF stock under the Base Case scenario is hidden USD. Compared to the current market price of 188.5 USD, AstraZeneca PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AZNCF Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
29
Median 3Y
4.5
Median 5Y
4.6
Industry
2.6
Forward
0
vs History
68
vs Industry
13
Median 3Y
33.6
Median 5Y
34.7
Industry
21.4
Forward
0.2
vs History
66
vs Industry
23
Median 3Y
19.6
Median 5Y
21.3
Industry
16.4
vs History
47
vs Industry
16
Median 3Y
38.9
Median 5Y
32.4
Industry
22.8
vs History
17
vs Industry
12
Median 3Y
5.6
Median 5Y
5.5
Industry
2.2
vs History
87
vs Industry
5
Median 3Y
45.6
Median 5Y
47.4
Industry
2.9
Forward
0.4
vs History
92
vs Industry
3
Median 3Y
55.5
Median 5Y
57.8
Industry
5.5
vs History
92
vs Industry
2
Median 3Y
138.7
Median 5Y
156.1
Industry
13
Forward
1.1
vs History
92
vs Industry
2
Median 3Y
222.7
Median 5Y
257.9
Industry
16.5
Forward
1.2
vs History
92
vs Industry
2
Median 3Y
200.5
Median 5Y
214.5
Industry
15.6
vs History
92
vs Industry
1
Median 3Y
302
Median 5Y
338.6
Industry
18.7
vs History
68
vs Industry
3
Median 3Y
29
Median 5Y
29.9
Industry
1.9

Multiples Across Competitors

AZNCF Competitors Multiples
AstraZeneca PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
AstraZeneca PLC
OTC:AZNCF
220.4B USD 5.1 31.5 108.8 159.3
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.6 37.3 40
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
493.6B USD 5.4 19.7 16.1 20.9
CH
Roche Holding AG
SIX:ROG
271.9B CHF 4.4 28.8 12.3 14.3
US
Merck & Co Inc
NYSE:MRK
276.3B USD 4.3 14.5 10.3 12.2
CH
Novartis AG
SIX:NOVN
219.7B CHF 4.9 19.1 12.1 15.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.3 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.5B USD 2.3 14.7 7.5 10.2
FR
Sanofi SA
PAR:SAN
102.8B EUR 1.5 7.4 6.8 6.8
P/E Multiple
Earnings Growth PEG
UK
AstraZeneca PLC
OTC:AZNCF
Average P/E: 23.1
31.5
37%
0.9
US
Eli Lilly and Co
NYSE:LLY
55.6
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.7
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.8
29%
1
US
Merck & Co Inc
NYSE:MRK
14.5
15%
1
CH
Novartis AG
SIX:NOVN
19.1
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
FR
Sanofi SA
PAR:SAN
7.4
26%
0.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
AstraZeneca PLC
OTC:AZNCF
Average EV/EBITDA: 400.7
108.8
10%
10.9
US
Eli Lilly and Co
NYSE:LLY
37.3
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.3
5%
2.5
US
Merck & Co Inc
NYSE:MRK
10.3
6%
1.7
CH
Novartis AG
SIX:NOVN
12.1
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
11.3
1%
11.3
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
FR
Sanofi SA
PAR:SAN
6.8
8%
0.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
AstraZeneca PLC
OTC:AZNCF
Average EV/EBIT: 1 713.1
159.3
23%
6.9
US
Eli Lilly and Co
NYSE:LLY
40
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.9
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.3
6%
2.4
US
Merck & Co Inc
NYSE:MRK
12.2
8%
1.5
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5
FR
Sanofi SA
PAR:SAN
6.8
15%
0.5